Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

Masimo releases haemoglobin and oxygen content monitors

Masimo : 16 September, 2008  (New Product)
Masimo has arranged the limited release of its noninvasive and continuous haemoglobin (SpHb) and oxygen content (SpOC) monitors, Radical-7 and Rad-87.
Masimo has also announced the FDA 510(k) clearance of its latest Rainbow family of adhesive sensors capable of noninvasively measuring total haemoglobin and oxygen content, along with oxygen saturation (SpO2), pulse rate, pleth variability index (PVI), and methaemoglobin (SpMet), for use with Masimo Rainbow SET-enabled devices.

The limited release of Masimo Radical-7 and Rad-87 Pulse CO-Oximeters with noninvasive and continuous total haemoglobin technology will allow select hospitals around the world to be the first to pioneer a breakthrough technology that may make it safer, faster, and easier for healthcare professionals to measure haemoglobin - without removing a drop of blood. Hospitals purchasing noninvasive haemoglobin devices and selected for the limited product release will work closely with Masimo to implement the technology in their facilities and provide data on its impact on patient care.

'Current methods for measuring total haemoglobin are invasive and only offer delayed and intermittent results,' stated Joe E Kiani, Masimo chairman and chief executive officer. 'We look forward to working closely with the first customers of our noninvasive haemoglobin monitoring technology to enable earlier and better clinical decisions, improve patient safety, and decrease costs.'

Haemoglobin is one of the most commonly-performed clinical laboratory tests with more than 400 million performed annually in the USA alone. A low haemoglobin level is called anaemia, a pervasive blood disorder that according to the World Health Organization (WHO) affects two billion people worldwide and causes one million deaths a year. Anaemia can be chronic or acute. Chronic anaemia is characterized by consistently low haemoglobin levels that can be the result of a diet deficiency, or illness such as cancer. Acute anaemia is characterized by a sudden drop in haemoglobin levels that can result from internal or external bleeding due to surgery or trauma.

Masimo noninvasive total haemoglobin (SpHb) and oxygen content (SpOC) are part of Masimo Rainbow SET Pulse CO-Oximetry, the first and only technology platform to noninvasively measure blood constituents and fluid responsiveness that previously required invasive procedures. In addition to haemoglobin and oxygen content, Rainbow measurements include: carboxyhaemoglobin (SpCO), methemoglobin (SpMet) and Pleth Variability Index (PVI) - in addition to the 'Gold Standard' measure-through-motion-and-low-perfusion performance of Masimo SET Oxygen Saturation (SpO2), Pulse Rate (PR) and Perfusion Index (PI).
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo